Manufacturing expiration dating policy cool things say dating profile
Veterinarians should be aware that Canadian global Food Animal Residue Avoidance Databank (g FARAD) will not provide advice on withdrawal period for compounded drugs.For additional information, contact the appropriate provincial/territorial professional regulatory authority or Health Products and Food Branch Inspectorate in Ottawa.Refer to section 7.0 Associated Documents/Links for a complete list of College of Pharmacies and Health Canada website links.Any substance or mixture of substances intended to be used in the manufacture of a drug (medicinal) product and that, when used in the production of a drug, becomes an active ingredient of the drug product.To promote good nutrition and informed use of drugs, food, medical devices and natural health products, and to maximize the safety and efficacy of drugs, food, natural health products, medical devices, biologics and related biotechnology products in the Canadian marketplace and health system.This document does not constitute part of the Food and Drugs Act (Act) or the Food and Drugs Regulations (Regulations) and in the event of any inconsistency or conflict between that Act or Regulations and this document, the Act or the Regulations take precedence.Other healthcare professionals such as physicians, veterinarians or dentists may also be involved in compounding activities when licensed to do so by the province/territory in which they practice.Drug manufacturing, on the other hand, is regulated by Health Canada under the federal .
This document is not intended to provide legal advice regarding the interpretation of the Act or Regulations.
A separate document will be provided by the Natural Health Products Directorate for compounding NHP.
In Canada, compounding of drugs is practised primarily by pharmacists as an integral part of their profession and is regulated by the respective regulatory authorities in each province/territory.
Adopting this process will help develop a consistent Canada wide approach ensuring that all products and activities are appropriately regulated.
Figure 1.0 - Process in Addressing Manufacturing and Compounding Issues - Flow chart showing the division between pharmaceutical companies, manufacturing activities and the Federal Government, and healthcare professionals, compounding activities and the Provincial/Territorial Regulating Bodies.